< Back to Listing

Infographic | Management of Cardiotoxicity Induced by BTK Inhibitors

Download File

Description:

Infographic | Management of Cardiotoxicity Induced by BTK Inhibitors

This infographic explains how BTK inhibitors to treat cancer can cause atrial fibrillation, ventricular arrhythmias and sudden cardiac death. It also advises how to monitor them.

Infographic Image | Click To Enlarge

Citations

  1. Tang CPS, Mcmullen J, Tam C. Cardiac side effects of bruton tyrosine kinase (BTK) inhibitors. Leuk Lymphoma. 2018;59(7):1554-1564.
  2. Leong DP, Caron F, Hillis C, et al. The risk of atrial fibrillation with ibrutinib use: a systematic review and meta-analysis. Blood. 2016;128:138–140.
  3. Curigliano G, Lenihan D, Fradley M, et al. Management of cardiac disease in cancer patients throughout oncological treatment : ESMO consensus recommendations. Ann Oncol 2020 ;31 :171-190. Doi :10.1016/j.annonc.2019.10.023

All infographics should be credited to "American College of Cardiology."

More ACC Infographics

Date: January 01, 2021    

Clinical Topics: Arrhythmias and Clinical EP, Cardio-Oncology, Implantable Devices, SCD/Ventricular Arrhythmias, Atrial Fibrillation/Supraventricular Arrhythmias

Keywords: Arrhythmias, Cardiac, Atrial Fibrillation, Drug Interactions, Cardiotoxicity